Published in Infect Immun on June 01, 1991
Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun (1995) 6.43
Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun (1996) 4.68
The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev (1992) 4.58
Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun (1994) 4.07
Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine. Clin Microbiol Rev (2001) 3.58
Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun (2000) 3.24
Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol (2000) 3.03
ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun (2000) 2.87
Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun (2001) 2.62
Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun (1995) 2.39
Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry. Infect Immun (1997) 2.37
Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun (2000) 2.29
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology (1995) 2.19
Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect Immun (1997) 2.05
Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle. Infect Immun (1997) 2.05
Cloning and B-cell-epitope mapping of MPT64 from Mycobacterium tuberculosis H37Rv. Infect Immun (1994) 1.98
B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect Immun (1998) 1.86
Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis. J Bacteriol (1996) 1.83
Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect Immun (1995) 1.72
Structure and function of a 40,000-molecular-weight protein antigen of Mycobacterium tuberculosis. Infect Immun (1992) 1.69
Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice. Infect Immun (1992) 1.55
Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis. Infect Immun (1999) 1.55
Proton motive force may regulate cell wall-associated enzymes of Bacillus subtilis. J Bacteriol (1993) 1.47
Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact. Clin Diagn Lab Immunol (2001) 1.45
Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect Immun (1998) 1.38
T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts. Infect Immun (1999) 1.38
CD4(+) T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice. Infect Immun (2000) 1.33
Role of Mycobacterium tuberculosis copper-zinc superoxide dismutase. Infect Immun (2001) 1.32
Redox homeostasis in mycobacteria: the key to tuberculosis control? Expert Rev Mol Med (2011) 1.32
Subcellular localization of the Iitracellular survival-enhancing Eis protein of Mycobacterium tuberculosis. Infect Immun (2001) 1.29
Early T-cell responses in tuberculosis immunity. Immunol Rev (2008) 1.28
Molecular cloning, expression, and immunogenicity of MTB12, a novel low-molecular-weight antigen secreted by Mycobacterium tuberculosis. Infect Immun (1998) 1.28
Compiling a molecular inventory for Mycobacterium bovis BCG at two growth rates: evidence for growth rate-mediated regulation of ribosome biosynthesis and lipid metabolism. J Bacteriol (2005) 1.28
Isoniazid induces expression of the antigen 85 complex in Mycobacterium tuberculosis. Antimicrob Agents Chemother (1996) 1.28
Identification of genes encoding exported Mycobacterium tuberculosis proteins using a Tn552'phoA in vitro transposition system. J Bacteriol (2000) 1.26
Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection. Immunology (1998) 1.24
Identification and characterization of a 29-kilodalton protein from Mycobacterium tuberculosis culture filtrate recognized by mouse memory effector cells. Infect Immun (1998) 1.24
Cloning and sequencing of the gene for alpha antigen from Mycobacterium avium and mapping of B-cell epitopes. Infect Immun (1993) 1.22
Identification of mycobacterium tuberculosis DNA sequences encoding exported proteins by using phoA gene fusions. J Bacteriol (1995) 1.22
Identification of secreted proteins of Mycobacterium tuberculosis by a bioinformatic approach. Infect Immun (2000) 1.18
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. J Bacteriol (2006) 1.17
Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine. Infect Immun (1999) 1.15
Mycobacterium tuberculosis (Mtb) isocitrate dehydrogenases show strong B cell response and distinguish vaccinated controls from TB patients. Proc Natl Acad Sci U S A (2004) 1.12
Secretion of an acid phosphatase (SapM) by Mycobacterium tuberculosis that is similar to eukaryotic acid phosphatases. J Bacteriol (2000) 1.11
Analysis of culture filtrate and cell wall-associated antigens of Mycobacterium paratuberculosis with monoclonal antibodies. Infect Immun (1997) 1.11
Influence of mouse strain and vaccine viability on T-cell responses induced by Mycobacterium bovis bacillus Calmette-Guérin. Infect Immun (1995) 1.10
Combinatorial use of antibodies to secreted mycobacterial proteins in a host immune system-independent test for tuberculosis. J Clin Microbiol (2001) 1.06
Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation. Immunology (2001) 1.05
Identification and characterization of a novel extracellular ferric reductase from Mycobacterium paratuberculosis. Infect Immun (1998) 1.05
Proteomic profiling of Mycobacterium tuberculosis identifies nutrient-starvation-responsive toxin-antitoxin systems. Mol Cell Proteomics (2013) 1.05
Mycobacterium tuberculosis Cpn60.2 and DnaK are located on the bacterial surface, where Cpn60.2 facilitates efficient bacterial association with macrophages. Infect Immun (2009) 1.05
The superoxide dismutase gene sodM is unique to Staphylococcus aureus: absence of sodM in coagulase-negative staphylococci. J Bacteriol (2002) 1.04
Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system. Infect Immun (2005) 1.03
Extracellular and cytoplasmic CuZn superoxide dismutases from Brugia lymphatic filarial nematode parasites. Infect Immun (1994) 1.02
Influence of genes from the major histocompatibility complex on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG. Infect Immun (1993) 1.01
Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery. Clin Microbiol Rev (2011) 1.01
Cloning, sequencing, and expression of the mig gene of Mycobacterium avium, which codes for a secreted macrophage-induced protein. Infect Immun (1997) 0.99
Analysis of the genes encoding the antigen 85 complex and MPT51 from Mycobacterium avium. Infect Immun (1997) 0.99
Contrasting transcriptional responses of a virulent and an attenuated strain of Mycobacterium tuberculosis infecting macrophages. PLoS One (2010) 0.98
Differential T-cell recognition of native and recombinant Mycobacterium tuberculosis GroES. Infect Immun (1999) 0.95
Expression of superoxide dismutase in Listeria monocytogenes. Appl Environ Microbiol (1994) 0.95
Antigens for CD4 and CD8 T cells in tuberculosis. Cold Spring Harb Perspect Med (2014) 0.93
Computational prediction and experimental assessment of secreted/surface proteins from Mycobacterium tuberculosis H37Rv. PLoS Comput Biol (2010) 0.91
Regulation of production of tumor necrosis factor alpha in monocytes stimulated by the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect Immun (1995) 0.90
Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis. Infect Immun (2005) 0.90
Variation in bacterial ATP level and proton motive force due to adhesion to a solid surface. Appl Environ Microbiol (2009) 0.88
Transcriptional profiling of Mycobacterium tuberculosis replicating ex vivo in blood from HIV- and HIV+ subjects. PLoS One (2014) 0.86
Phenylalanine-rich peptides potently bind ESAT6, a virulence determinant of Mycobacterium tuberculosis, and concurrently affect the pathogen's growth. PLoS One (2009) 0.85
Extracellular and cytosolic iron superoxide dismutase from Mycobacterium bovis BCG. Clin Diagn Lab Immunol (1998) 0.84
Rhodococcus equi secreted antigens are immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi infection. Infect Immun (2003) 0.84
Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection. Immunology (2007) 0.84
Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate antigen. BMC Microbiol (2010) 0.83
Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells. PLoS One (2015) 0.82
Assessment of the BD MGIT TBc identification test for the detection of Mycobacterium tuberculosis complex in a network of mycobacteriology laboratories. Biomed Res Int (2014) 0.81
Infection of Burkholderia cepacia induces homeostatic responses in the host for their prolonged survival: the microarray perspective. PLoS One (2013) 0.81
Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants. J Clin Microbiol (2010) 0.80
Profiling of Burkholderia cepacia secretome at mid-logarithmic and early-stationary phases of growth. PLoS One (2011) 0.80
Mycobacterium tuberculosis infection in young children: analyzing the performance of the diagnostic tests. PLoS One (2014) 0.79
Immune regulatory activities of early secreted antigenic target of 6-kD protein of Mycobacterium tuberculosis and implications for tuberculosis vaccine design. Tuberculosis (Edinb) (2011) 0.79
Antibody response to a sterile filtered PPD tuberculin in M. bovis infected and M. bovis sensitized cattle. BMC Vet Res (2010) 0.78
Non-major histocompatibility complex-restricted cytotoxic activity of blood mononuclear cells stimulated with secreted mycobacterial proteins and other mycobacterial antigens. Infect Immun (1994) 0.77
Mycobacterium tuberculosis is resistant to streptolydigin. Tuberculosis (Edinb) (2013) 0.77
Isocitrate dehydrogenase of Helicobacter pylori potentially induces humoral immune response in subjects with peptic ulcer disease and gastritis. PLoS One (2008) 0.77
Mycobacterial ESX-1 secretion system mediates host cell lysis through bacterium contact-dependent gross membrane disruptions. Proc Natl Acad Sci U S A (2017) 0.76
Rapid Immunochromatographic Test for the Identification and Discrimination of Mycobacterium tuberculosis Complex Isolates from Non-tuberculous Mycobacteria. J Clin Diagn Res (2014) 0.75
ESX systems and the Mycobacterial Cell Envelope: What's the connection? J Bacteriol (2017) 0.75
Comprehensive definition of human immunodominant CD8 antigens in tuberculosis. NPJ Vaccines (2017) 0.75
Modulation of Roquin Function in Myeloid Cells Reduces Mycobacterium tuberculosis-Induced Inflammation. J Immunol (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem (1981) 29.21
Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem (1971) 28.59
Protein secretion in Escherichia coli. Annu Rev Microbiol (1985) 6.74
Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun (1991) 4.57
Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG. Infect Immun (1986) 3.80
Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun (1988) 3.79
Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis. Infect Immun (1989) 3.64
Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect Immun (1988) 3.35
Cloning and characterization of the gene for immunogenic protein MPB64 of Mycobacterium bovis BCG. Infect Immun (1989) 2.62
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Interspecies reactivity of five monoclonal antibodies to Mycobacterium tuberculosis as examined by immunoblotting and enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 2.42
The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol (1988) 2.38
Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex. Infect Immun (1990) 2.06
Biological activity of protein antigens isolated from Mycobacterium tuberculosis culture filtrate. Infect Immun (1988) 2.01
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
Quantitative and qualitative studies on the major extracellular antigen of Mycobacterium tuberculosis H37Rv and Mycobacterium bovis BCG. Am Rev Respir Dis (1990) 1.86
Superoxide dismutase from Mycobacterium tuberculosis. J Biochem (1976) 1.53
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
Identification, sequencing, and expression of Mycobacterium leprae superoxide dismutase, a major antigen. Infect Immun (1990) 1.37
Leprosy: understanding protective immunity. Immunol Today (1989) 1.31
Rapid methods for counting mycobacteria--comparison of methods for extraction of mycobacterial adenosine triphosphate (ATP) determined by firefly luciferase assay. Tubercle (1985) 1.21
Characterization of distinct layers of the Mycobacterium avium envelope in respect of their composition by fatty acids, proteins, oligosaccharides and antigens. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 1.11
Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect Immun (1988) 3.35
A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A (1971) 2.55
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Interspecies reactivity of five monoclonal antibodies to Mycobacterium tuberculosis as examined by immunoblotting and enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 2.42
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis (2004) 2.20
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16
Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05
DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania. J Clin Microbiol (1995) 2.04
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
Quantitative and qualitative studies on the major extracellular antigen of Mycobacterium tuberculosis H37Rv and Mycobacterium bovis BCG. Am Rev Respir Dis (1990) 1.86
Production and partial characterization of monoclonal hybridoma antibodies to Mycobacterium tuberculosis. Acta Pathol Microbiol Immunol Scand C (1985) 1.83
Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70
Structure and function of a 40,000-molecular-weight protein antigen of Mycobacterium tuberculosis. Infect Immun (1992) 1.69
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
MPB 64 possesses 'tuberculosis-complex'-specific B- and T-cell epitopes. Scand J Immunol (1991) 1.62
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
The antigens of Mycobacterium tuberculosis, H37Rv, studied by crossed immunoelectrophoresis. Comparison with a reference system for Mycobacterium bovis, BCG. Scand J Immunol (1988) 1.56
Evidence that protein antigen b of Mycobacterium tuberculosis is involved in phosphate metabolism. J Gen Microbiol (1990) 1.55
Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54
In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
A family of cross-reacting proteins secreted by Mycobacterium tuberculosis. Scand J Immunol (1992) 1.41
Comparison of the immunological activity of five defined antigens from Mycobacterium tuberculosis in seven inbred guinea pig strains. The 38-kDa antigen is immunodominant. Scand J Immunol (1990) 1.34
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32
ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
Repertoires of antibodies to culture filtrate antigens in different mouse strains infected with Mycobacterium bovis BCG. Infect Immun (1990) 1.21
Examination for tubercle bacili by fluorescence microscopy. Scand J Respir Dis (1966) 1.17
Phosphorylcholine determinants in six pneumococcal capsular polysaccharides detected by monoclonal antibody. Infect Immun (1984) 1.16
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology (1983) 1.14
The migration of lymphocytes in the fetal lamb. Eur J Immunol (1979) 1.12
Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis (1988) 1.11
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Results of the third immunology of leprosy/immunology of tuberculosis antimycobacterial monoclonal antibody workshop. Infect Immun (1992) 1.09
Typing of clinical Mycobacterium avium complex strains cultured during a 2-year period in Denmark by using IS1245. J Clin Microbiol (1999) 1.07
Bordetella pertussis and chronic cough in adults. Clin Infect Dis (1999) 1.06
Comparison of various staining methods for demonstration of tubercle bacilli in suputum by direct microscopy. Bull Int Union Tuberc (1969) 1.03
Serovars of Mycobacterium avium complex isolated from patients in Denmark. J Clin Microbiol (1994) 1.01
The interaction between pertussis toxin and 10 monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1987) 1.00
Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis (1997) 0.99
Production of specific antibodies against protein A fusion proteins. EMBO J (1986) 0.97
Affinity purification, biological characterization and serological evaluation of defined antigens from Mycobacterium tuberculosis. Trop Med Parasitol (1990) 0.96
Lymphocyte recirculation in the sheep fetus. Ciba Found Symp (1980) 0.96
Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96
T-cell recirculation in the sheep: migratory properties of cells from lymph nodes. Immunology (1982) 0.96
The actions of interferon are potentiated at elevated temperature. Nature (1978) 0.96
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine (1997) 0.95
Bordetella pertussis diagnosed by polymerase chain reaction. APMIS (1994) 0.94
Susceptibility to diphtheria in populations vaccinated before and after elimination of indigenous diphtheria in Denmark. A comparative study of antitoxic immunity. Acta Pathol Microbiol Immunol Scand C (1987) 0.93
Lymphocyte proliferative responses and the occurrence of dermatophilosis in cattle naturally infested with Amblyomma variegatum. Vet Parasitol (1994) 0.93
Collection of lymph from single lymph nodes and the intestines of fetal lambs in utero. Int Arch Allergy Appl Immunol (1979) 0.92
The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand C (1986) 0.92
Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III. Vaccine (1996) 0.92
Plasmid profiles of mycobacterium avium/intracellulare isolated from patients with AIDS or cervical lymphadenitis and from environmental samples. Scand J Infect Dis (1989) 0.92
Immunity against diphtheria and tetanus in human immunodeficiency virus-infected Danish men born 1950-59. APMIS (1992) 0.91
Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci U S A (1993) 0.91
The Isopaque-Ficoll method re-evaluated: selective loss of autologous rosette-forming lymphocytes during isolation of mononuclear cells from human peripheral blood. Scand J Immunol (1980) 0.90
Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine (1993) 0.90
Double-antibody sandwich enzyme-linked immunosorbent assay for rapid detection of toxin-producing Corynebacterium diphtheriae. J Clin Microbiol (1987) 0.90
In vitro studies on normal, stimulated and immunologically activated mouse macrophages. III. Intracellular multiplication of Listeria monocytogenes. Acta Pathol Microbiol Scand C (1977) 0.90
Monocyte functions in diabetes mellitus. Acta Pathol Microbiol Immunol Scand C (1982) 0.90
Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. APMIS (1997) 0.89
An improved technique for obtaining E rosettes with human lymphocytes and its use for B cell purification. J Immunol Methods (1976) 0.89
Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay. J Immunol Methods (1996) 0.89
The effect of interferon on lymphocyte-mediated effector cell functions: selective enhancement of natural killer cells. Cell Immunol (1979) 0.89
Increased expression of beta 2-microglobulin and histocompatibility antigens on human lymphoid cells induced by interferon. J Interferon Res (1981) 0.89
Detection of mycobacteria from blood and bone marrow: a decade of experience. APMIS (1992) 0.89
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine. Vaccine (1998) 0.88
Epidemiology of tuberculosis in HIV-infected patients in Denmark. Scand J Infect Dis (1999) 0.88
Identification of a disulfide bridge connecting the alpha-subunits of the extracellular domain of the insulin receptor. Biochem Biophys Res Commun (1992) 0.88
Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1. Infect Immun (1977) 0.88
The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans. FEMS Microbiol Immunol (1991) 0.88
Correlation between in vivo and in vitro functional tests for activated macrophages. Infect Immun (1979) 0.87
Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine. Clin Diagn Lab Immunol (1995) 0.87
Fall-off in immunity following diphtheria revaccination--an 8 year follow-up study. APMIS (1996) 0.86
In vitro effect of mitogen-activated speen cells and their culture supernatants on mouse peritoneal macrophages as assayed by intracellular killing of Listeria monocytogenes and content of beta-galactosidase. J Reticuloendothel Soc (1979) 0.86
Is the acute encephalopathy test in mice suited for control of pertussis vaccines? Dev Biol Stand (1985) 0.86
Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles. Int Arch Allergy Appl Immunol (1978) 0.86
Immunity to tetanus and diphtheria in rural Africa. Am J Trop Med Hyg (1997) 0.86
Corticosteroids decrease the expression of beta 2-microglobulin and histocompatibility antigens on human peripheral blood lymphocytes in vitro. Clin Exp Immunol (1981) 0.85
Revaccination of adults against diphtheria. II: Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination. Acta Pathol Microbiol Immunol Scand C (1986) 0.85
Firefly luciferase assay of adenosine triphosphate as a tool of quantitation of the viability of BCG vaccines. Biologicals (1995) 0.84
Characterisation of ovine Bordetella parapertussis isolates by analysis of specific endotoxin (lipopolysaccharide) epitopes, filamentous haemagglutinin production, cellular fatty acid composition and antibiotic sensitivity. FEMS Microbiol Lett (1995) 0.84
Stimulation of human lymphocytes by cytomegalovirions and dense bodies. Med Microbiol Immunol (1978) 0.83
Infection with Mycobacterium bovis in a patient with AIDS: a late complication of BCG vaccination. Scand J Infect Dis (1992) 0.83